Genome Sequence of SCB34, a Sequence Type 131 Multidrug-Resistant Escherichia coli Isolate Causing Neonatal...

Area of Science:

• Microbiology
• Genomics
• Infectious Diseases

Background:

• Neonatal bacteremia is a serious infection in newborns.
• Multidrug-resistant bacteria pose a significant public health threat.
• Escherichia coli sequence type 131 (ST131) is a globally prevalent and often virulent strain.

Purpose of the Study:

• To characterize the whole genome of SCB34, a multidrug-resistant Escherichia coli isolate.
• To investigate the genetic basis of the high invasiveness and drug resistance of SCB34.
• To provide genomic data for understanding neonatal bacteremia caused by E. coli ST131.

Main Methods:

• Whole-genome sequencing of the SCB34 isolate using Illumina MiSeq platform with a 250-bp library.
• De novo assembly of sequencing reads utilizing the A5 assembly pipeline.
• Genome annotation performed using the RAST server.

Main Results:

• The complete genome size of SCB34 was determined to be 5,227,742 bp.
• The assembly resulted in a total contig length of 5,227,742 bp.
• The RAST server provided comprehensive annotation of the assembled genome.

Conclusions:

• The genomic characterization of SCB34 provides insights into the genetic makeup of an invasive, multidrug-resistant E. coli ST131 strain.
• Understanding the genome of SCB34 can aid in developing targeted therapies and prevention strategies for neonatal bacteremia.
• This study contributes valuable genomic data for the surveillance and control of E. coli ST131 infections.